×
ADVERTISEMENT

melanoma

Teledermoscopy Adds a Dose of Health Equity to Skin Cancer

Collecting images of suspicious-looking skin growths and sending them off-site for specialists to analyze is as ...

APRIL 24, 2025

Survivorship Planning for Melanoma Patients

3 Questions for Christina Davis, PharmD, Clinical Oncology Pharmacy Specialist, University of Colorado Anschutz ...

MARCH 14, 2025

Pharmacists Play Important Role in Sun Safety Education

Counseling survivors of melanoma on sun protection and skin health is an important role for pharmacists, since ...

MARCH 14, 2025

Remote Telemedicine Tool Highly Accurate in Diagnosing Melanoma

Sending images of suspicious-looking skin growths to off-site for specialists to analyze is as accurate in ...

MARCH 14, 2025

FDA Approves Opdivo Qvantig for Subcutaneous Injection

The FDA approved nivolumab plus hyaluronidase-nvhy (Opdivo Qvantig, Bristol Myers Squibb) for subcutaneous ...

DECEMBER 30, 2024

FDA Approves Tecentriq Hybreza for Subcutaneous Injection for All Adult Indications of IV Tecentriq

The FDA has approved Tecentriq Hybreza for subcutaneous injection as the intravenous formulation of Tecentriq.

SEPTEMBER 16, 2024

Amtagvi Granted Accelerated Approval for Unresectable or Metastatic Melanoma

The FDA granted accelerated approval to Amtagvi for adult patients with unresectable or metastatic melanoma ...

FEBRUARY 20, 2024

FDA Approves Opdivo for Adjuvant Treatment of Select Patients With Stage IIB/C Melanoma

The FDA approved nivolumab (Opdivo, Bristol Myers Squibb) for the adjuvant treatment of completely resected stage ...

OCTOBER 17, 2023

FDA Approves Hepzato Kit as a Liver-Directed Treatment for Uveal Melanoma

The FDA approved Hepzato Kit as a liver-directed treatment for adults with uveal melanoma with unresectable hepatic ...

AUGUST 17, 2023

Mediterranean Diet Boosts Immunotherapy Response

Falafel and hummus are not just delicious, they also could save your life, according to data presented at United ...

DECEMBER 22, 2022

Nivolumab Plus Relatlimab Approved to Treat Metastatic Melanoma

The FDA approved a fixed-dose combination of the programmed death-1–blocking antibody nivolumab and ...

MARCH 22, 2022

FDA Approves Uveal Melanoma Therapy That Targets Specific Cancer Cells

The FDA approved tebentafusp-tebn (Kimmtrak, Immunocore), a bispecific T-cell engager designed to redirect the ...

JANUARY 27, 2022

Load more